Astellas Pharma Inc. is a Japanese pharmaceutical company with a global presence. It has been engaged in the business of pharmaceutical products since 2004 and has established itself as a trusted name ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

TOKYO, May 19, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies ...

The Astellas UK affiliate was already suspended for a year in June 2016 after it took doctors to a medical conference in Milan, Italy which included a presentation about benefits of its Xtandi ...

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders.

Genmab A/S announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical Oncology (ASCO) ...

Decades into its tenure as a drug seller, CSL Behring has finally dipped its toe into the waters of TV advertising. | Decades ...

The global antibody drug conjugate (ADC) market is thriving, fueled by rising cancer prevalence, technological advancements, and demand for targeted therapies. ADCs, which merge monoclonal antibodies ...

3382.T Seven & i Holdings Co., Ltd.